(Circulation. 1999;100:2400.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Creatine Kinase-MB Enzyme Elevation Following Successful Saphenous Vein Graft Intervention Is Associated With Late Mortality
From the Cardiovascular Research Foundation, Washington Hospital Center, Washington, DC.
Background—Although the risk for development of creatine kinase (CK-MB) elevation after saphenous vein graft (SVG) intervention is high, its prognostic significance remains unknown. This study evaluated the impact of periprocedural CK-MB elevation on late clinical events following successful SVG angioplasty.
Methods and Results—We studied 1056 consecutive patients with successful (defined by angiographic success and absence of major complications) intervention of 1693 SVG lesions. These patients were grouped as normal CK-MB (n=556), minor CK-MB rise (CK-MB 1 to 5 times normal, n=339), and major CK-MB rise (CK-MB >5 times normal, n=161). There were no differences in major clinical events at 30-day follow-up among the 3 groups. However, 1-year mortality was 4.8%, 6.5%, and 11.7%, respectively, P<0.05 (ANOVA). Even within a population without any intraprocedure or in-hospital complications (n=727, 69% of the overall cohort), 1-year mortality remained significantly higher with CK-MB elevation: 2.4%, 5.5%, and 10.7%, respectively, P<0.05 (ANOVA). Multivariate analysis revealed major CK-MB elevation as the strongest independent predictor of late mortality (odds ratio 3.3, with 95% CI 1.7 to 6.2), followed by diabetes mellitus (odds ratio 2.6, with 95% CI 1.5 to 4.5).
Conclusions—Major CK-MB elevation occurs after 15% of otherwise successful SVG interventions and is associated with increased late mortality.
Key Words: angioplasty • stents • myocardial infarction • creatine kinase
This article has been cited by other articles:
 |
|
 |
|
  D. J. Kereiakes, M. A. Turco, J. Breall, N. Z. Farhat, R. L. Feldman, B. McLaurin, J. J. Popma, L. Mauri, P. Zimetbaum, J. Massaro, et al. A Novel Filter-Based Distal Embolic Protection Device for Percutaneous Intervention of Saphenous Vein Graft Lesions: Results of the AMEthyst Randomized Controlled Trial J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 248 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Kirtane, E. R. Heyman, C. Metzger, J. A. Breall, and J. P. Carrozza Jr Correlates of Adverse Events During Saphenous Vein Graft Intervention With Distal Embolic Protection: A PRIDE Substudy J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 186 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Coolong, D. S. Baim, R. E. Kuntz, A. J. O'Malley, S. Marulkar, D. E. Cutlip, J. J. Popma, and L. Mauri Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients Circulation, February 12, 2008; 117(6): 790 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mauri, D. Cox, J. Hermiller, J. Massaro, J. Wahr, S. W. Tay, M. Jonas, J. J. Popma, J. Pavliska, D. Wahr, et al. The PROXIMAL Trial: Proximal Protection During Saphenous Vein Graft Intervention Using the Proxis Embolic Protection System: A Randomized, Prospective, Multicenter Clinical Trial J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1442 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Larose Below Radar: Contributions of Cardiac Magnetic Resonance to the Understanding of Myonecrosis After Percutaneous Coronary Intervention Circulation, August 15, 2006; 114(7): 620 - 622. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jonas, G. W. Stone, R. Mehran, J. Hermiller, R. Feldman, H. C. Herrmann, D. A. Cox, R. E. Kuntz, J. J. Popma, C. Rogers, et al. Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection Eur. Heart J., April 2, 2006; 27(8): 920 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Herrmann Peri-procedural myocardial injury: 2005 update Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Carrozza Jr, M. Mumma, J. A. Breall, A. Fernandez, E. Heyman, C. Metzger, and for the PRIDE Study Investigators Randomized Evaluation of the TriActiv Balloon-Protection Flush and Extraction System for the Treatment of Saphenous Vein Graft Disease J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1677 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Gorog, R. A. Foale, and I. Malik Distal Myocardial Protection During Percutaneous Coronary Intervention: When and Where? J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1434 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bhatt and E. J. Topol Periprocedural Cardiac Enzyme Elevation Predicts Adverse Outcomes Circulation, August 9, 2005; 112(6): 906 - 922. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cutlip and R. E. Kuntz Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes Circulation, August 9, 2005; 112(6): 916 - 923. [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur. Heart J., April 2, 2005; 26(8): 804 - 847. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Cohen, S. A. Murphy, D. S. Baim, T. A. Lavelle, R. H. Berezin, D. E. Cutlip, K. K.L. Ho, R. E. Kuntz, and the SAFER Trial Investigators Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: Results from the SAFER trial J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1801 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. S. Jonjev, S. Nicin, V. Mujovic, L. Petrovic, and N. Radovanovic Prostacyclin Reduces Incidence of Myocardial Damage After Coronary Endarterectomy Ann. Thorac. Surg., October 1, 2004; 78(4): 1299 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rogers, R. Huynh, P. A. Seifert, B. Chevalier, J. Schofer, E. R. Edelman, G. Toegel, A. Kuchela, A. Woupio, R. E. Kuntz, et al. Embolic Protection With Filtering or Occlusion Balloons During Saphenous Vein Graft Stenting Retrieves Identical Volumes and Sizes of Particulate Debris Circulation, April 13, 2004; 109(14): 1735 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O. Williams A twist in our understanding of enzyme elevation after coronary intervention J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1906 - 1908. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, D. A. Cox, J. Babb, D. Nukta, L. Bilodeau, L. Cannon, T. D. Stuckey, J. Hermiller, E. A. Cohen, R. Low, et al. Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries J. Am. Coll. Cardiol., December 3, 2003; 42(11): 2007 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Schachinger, C. W. Hamm, T. Munzel, M. Haude, S. Baldus, E. Grube, T. Bonzel, T. Konorza, R. Koster, R. Arnold, et al. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1360 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Baim Percutaneous treatment of saphenous vein graft disease: The ongoing challenge J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1370 - 1372. [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Ioannidis, E. Karvouni, and D. G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1406 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Sangiorgi and A Colombo Embolic protection devices Heart, September 1, 2003; 89(9): 990 - 992. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, C. Rogers, J. Hermiller, R. Feldman, P. Hall, R. Haber, A. Masud, P. Cambier, R. P. Caputo, M. Turco, et al. Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts Circulation, August 5, 2003; 108(5): 548 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Stankovic, A. Colombo, P. Presbitero, F. van den Branden, L. Inglese, C. Cernigliaro, L. Niccoli, A. L. Bartorelli, P. Rubartelli, N. Reifart, et al. Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial Circulation, July 8, 2003; 108(1): 37 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P Marso, B. D Bliven, J. A House, G. F Muehlebach, and A.M. Borkon Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality Eur. Heart J., July 2, 2003; 24(14): 1323 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Ashby, G. Dangas, E. A. Aymong, I. Iakovou, F. Kuepper, R. Mehran, G. W. Stone, M. B. Leon, and J. W. Moses Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection J. Am. Coll. Cardiol., March 5, 2003; 41(5): 749 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, C. Rogers, S. Ramee, C. White, R. E. Kuntz, J. J. Popma, J. George, S. Almany, and S. Bailey Distal filter protection during saphenous vein graft stenting: Technical and clinical correlates of efficacy J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1882 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Ellis, D. Chew, A. Chan, P. L. Whitlow, J. P. Schneider, and E. J. Topol Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy Circulation, September 3, 2002; 106(10): 1205 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.J. Brener, S.G. Ellis, J. Schneider, and E.J. Topol Frequency and long-term impact of myonecrosis after coronary stenting Eur. Heart J., June 1, 2002; 23(11): 869 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Baim, D. Wahr, B. George, M. B. Leon, J. Greenberg, D. E. Cutlip, U. Kaya, J. J. Popma, K. K.L. Ho, and R. E. Kuntz Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts Circulation, March 19, 2002; 105(11): 1285 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Keeley, C. A. Velez, W. W. O'Neill, and R. D. Safian Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts J. Am. Coll. Cardiol., September 1, 2001; 38(3): 659 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, R. Mehran, G. Dangas, A. J. Lansky, R. Kornowski, and M. B. Leon Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients Circulation, August 7, 2001; 104(6): 642 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]
|
|
|
|
 |
|
 Enzyme Elevation, Vein Grafts, and Late Mortality Journal Watch Cardiology, January 14, 2000; 2000(114): 3 - 3. [Full Text]
|
|